Featured
July 16, 2020 by Joseph Morton
War is a part of human nature. It’s the greatest driver of human innovation, and if we’re inclined to be cynical we could state that it’s the key reason our civilization is advanced as it is. If it weren’t for the catalyst of hundreds of years of continuous war, including the prospect of mutually assured […] June 26, 2020 by Joseph Morton
One of Roadman Investments (LITT.V) subsidiaries, CLOV Biopharma, recently completed its research program at UBC on cedar leaf oil vapour, but the Securities Exchange Commission (SEC) doesn’t care. The research program has taken a bit longer than the company would have liked, courtesy of COVID-19, but the company’s doctors have acquired most of the exemptions […] June 18, 2020 by Chris Parry
The big knock on shroom companies in the public markets right now is that most of them are chancers rather than pioneers – markets guys looking to acquire any asset that could convince a psychedelics investor to toss coin at their stock. The track record of EGF Theramed (aka Theramed, aka Evatrade Health, aka […] Latest
August 4, 2020 by Joseph Morton
Mydecine Innovations Group’s (MYCO.C) subsidiary Mindleap Health expanded its digital therapeutic services, dealing specifically with addiction, by adding three new programs to its platform. This company is no stranger to finding solutions to mental health issues, but Mindleap’s intention here is providing a contribution to the evolution of mental health and facilitating the mass adoption […] July 20, 2020 by Joseph Morton
Red Light Holland (TRIP.C) has engaged Delaware-based virtual reality company to develop a shopping experience VR module that will explain the effects of microdosing on magic truffles on the human brain, and a virtual reality avatar that will put Red Light’s brand front and centre. RadixMotion is a VR company that uses the latest neuroscience […] June 22, 2020 by Joseph Morton
Liberty Leaf Holdings (LIB.C) made a right-turn into psychedelics with their latest acquisition of Nova Mentis Biotech today. Now that mushrooms have started gathering serious attention, there are plenty of companies out there throwing their research and development bucks into finding what psilocybin and its underlying chemical agent, psilocin, can do for their bottom line. […] June 18, 2020 by Chris Parry
YUKOTERRE HOLDINGS (YT.C) / SILO If you were one of those who contributed part of the $350k mining explorer Yukoterre Holdings raised in IPO last September, and have been wondering what the hell that company was doing with your money other than rewarding its executives with options – three financial quarters later, your questions have […]
